H.C. Wainwright raised the firm’s price target on Sensus Healthcare to $10 from $8 and keeps a Buy rating on the shares following the Q1 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRTS:
- Sensus Healthcare reports Q1 EPS 14c, two estimates (5c)
- Sensus Healthcare price target raised to $10 from $7 at Maxim
- Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold
- Sensus Healthcare’s SRT-100 system selected by emergency hospital in Tel Aviv
- Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats